In agreement with the fact that LEKTI inhibits matriptase-dependent skin desquamation in Netherton Syndrome by the direct inhibition of KLK5 [11] and our data shows that concomitant expression of LEKTI with matriptase rescues aberrant KLK5 expression. Here, ST14 is linked to Netherton syndrome.